Eli Lilly and Company (LLY) closed at $1,152.70 on September 19, 2026, adding just 0.02% over the prior 24-hour period. The pharmaceutical giant's market capitalization stood at $1,027.24 billion, keeping it among the largest publicly traded companies by that measure.
Looking at a broader window, LLY advanced 3.36% over the past seven days, suggesting some recovery momentum in the near term. The daily gain, while minimal, extended that positive streak into the current session.
Despite the recent uptick, the 30-day picture tells a more cautious story. Eli Lilly shares have fallen 10.05% over the past month, reflecting a notable pullback from levels seen roughly four weeks ago.
The contrast between the seven-day gain and the steeper 30-day decline illustrates the mixed price action surrounding LLY in recent weeks. The stock's trajectory over this period reflects broader volatility within the large-cap pharmaceutical sector.
